Defining Ocular Surface Disease Activity and Damage Indices by an International Delphi Consultation-Reference-Cited by-同舟云学术

Defining Ocular Surface Disease Activity and Damage Indices by an International Delphi Consultation

Published:2017-01 Issue:1 Volume:15 Page:97-111
ISSN:1542-0124
Container-title:The Ocular Surface
language:en
Short-container-title:The Ocular Surface

Author:

Mathewson Priscilla A.,Williams Geraint P.,Watson Stephanie L.,Hodson James,Bron Anthony J.,Rauz Saaeha,Ahmad Sajjad,Bron Anthony,Burton Matthew,Dart John K.,Figueiredo Francisco,Geerling Gerd,Hawksworth Nicholas,Jacobs Deborah,Kaye Stephen,Kolli S. Sai,Larkin D. Frank,Mantry Sanjay,Murray Philip I.,Liu Christopher,Rauz Saaeha,Shortt Alex,Tomlins Paul J.,Verity David,Watson Stephanie L.,Williams Geraint P.,Willoughby Colin

Publisher

Elsevier BV

Subject

Ophthalmology

Reference49 articles.

1. The ocular surface: the challenge to enable and protect vision;Gipson;Invest Ophthalmol Vis Sci,2007

2. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators;Chan;Arch Dermatol,2002

3. International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I);Ogawa;Sci Rep,2013

4. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy;De Rojas;Br J Ophthalmol,2007

5. Monitoring of activity and progression in cicatrising conjunctivitis;Elder,1997

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bi-DenseNet: Automatic recognition of ocular surface disease using smartphone imaging;Biomedical Signal Processing and Control;2024-10

2. Efficient capture of dry eye data from the real world: The Save Sight Dry Eye Registry;AJO International;2024-10

3. Swept-source optical coherence tomography in ocular surface diseases: anterior segment analysis repeatability and its limits;Frontiers in Medicine;2024-08-02

4. Real-World Experience in the Use of Immunosuppression for the Management of Inflammatory Eye Disease;Ocular Immunology and Inflammation;2024-02-13

5. Reducing the carbon footprint of cataract surgery: co-creating solutions with a departmental Delphi process;Eye;2023-12-28